Table 1.
Clinical information for the primary MCD, MN, FSGS patients and normal controls
| Parameters | MCD-NS | MCD-PR | MCD-CR | MN-NS | FSGS-NS | Controls |
|---|---|---|---|---|---|---|
| Number | 7 | 8 | 4 | 8 | 5 | 5 |
| Male/female | 3/4 | 4/4 | 2/2 | 5/3 | 4/1 | 3/2 |
| Age [yr] | 33.7 ± 14.5 | 26.1 ± 9.7 | 23.8 ± 7.7 | 39.9 ± 20.4 | 30.8 ± 14.1 | 35.8 ± 16.3 |
| Duration of disease [months] | 1.6 ± 1.5 | 17.1 ± 11.4 | 36.9 ± 8.1 | 48.7 ± 24.9 | 5.7 ± 5.5 | - |
| Urinary protein [g/d] | 9.9 ± 6.0 | 1.6 ± 0.9 | 0.15 ± 0.08 | 9.3 ± 5.5 | 9.0 ± 3.9 | - |
| Serum Albumin [g/L] | 20.4 ± 6.9 | 27.3 ± 6.6 | 31.3 ± 9.5 | 20.4 ± 3.6 | 20.3 ± 4.5 | 46.5 ± 0.7 |
| Serum Creatinine [μmol/L] | 76.8 ±18.5 | 61.7 ± 21.0 | 71.0 ± 10.1 | 84.8 ± 44.1 | 69.2 ± 19.4 | 63.5 ± 11.3 |
| Glucocorticoids treated/untreated | 4/3 | 2/6 | 2/2 | 6/2 | 1/4 | - |
Values are means ± standard deviation; CR, complete remission; NS, nephrotic syndrome; PR, partial remission; FSGS, focal segmental glomerulosclerosis; MCD, minimal change disease; MN, membranous nephropathy.